Insmed Incorporated: Jefferies cuts target price to $165 from $175
INSM•Jefferies cut its target price for Insmed Incorporated to $165 from $175.
Related News
OPKO jumps on sale of select assets to Labcorp for up to $872 million
OPK•
Sigma Lithium Corporation: Canaccord Genuity cuts target price to C$26 from C$31.5
SGML•
Sanofi selects Recursion immunology drug candidate for development
RXRX•
Targa Resources Corp.: Jefferies cuts target price to $326 from $345
TRGP•
Aurora Mobile - GPTbots.ai enters partnership with AI Storm Co
JG•